Published on Published March 29, 2026 Silicon Syringes and the End of Biological Guesswork ArtificialIntelligenceBiotechnologyFinancePharmaceuticals Eli Lilly’s $2.75 billion deal with Insilico marks a definitive shift from the messy world of biology to the tidy, if expensive, world of AI-driven drug discovery. Read more →